Syndrome of inappropriate ADH secretion attributed to the serotonin re- uptake inhibitors, venlafaxine and paroxetine

Netherlands Journal of Medicine

Volumn 50, Issue 6, 1997, Pages 243-245

  Meynaar, I A ^a   Peeters, A J ^a   Mulder, A H ^a   Ottervanger, J P ^b  

^a Reinier de Graaf Gasthuis ^*  (Netherlands)

^b Netherlands Ctr Monitoring A   (Netherlands)

Author keywords

Antidepressants; Hyponatraemia; Paroxetine; SIADH; Venlafaxine

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

AGED; ARTICLE; CASE REPORT; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FEMALE; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; MALE; VASOPRESSIN RELEASE;

AGED; AGED, 80 AND OVER; CYCLOHEXANOLS; FEMALE; HUMANS; INAPPROPRIATE ADH SYNDROME; MALE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS;

EID: 0030808015     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00005-3     Document Type: Article

References (7)

1. Finley PR. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 1994;28:1359-1369.
2. Holliday SM, Benfield P. Venlafaxine: a review of its pharmacology and therapeutic potential in depression. Drugs 1995;49:280-294.
3. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790-806.
4. Goddard C, Paton C. Hyponatraemia associated with paroxetine. Br Med J 1992;305:1332.
5. Chua TP, Vong SK. Hyponatraemia associated with paroxetine [Letter]. Br Med J 1993;306:143.
6. Ten Holt WL, Klaassen CHL, Schrijver G. Ernstige hyponatriëmie, mogelijk door inadequate antidiuretisch-hormoonsecretie, bij gebruik van het antidepressivum fluoxetine. Ned Tijdschr Geneeskd 1994;138:1181-1183.
7. Spigset O, Hedenhalm K. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Safety 1995;12:209-225.